Literature DB >> 9857057

Hop as an adaptor in the heat shock protein 70 (Hsp70) and hsp90 chaperone machinery.

S Chen1, D F Smith.   

Abstract

Hop, an abundant and conserved protein of unresolved function, binds concomitantly with heat shock protein 70 (Hsp70) and Hsp90, participates with heat shock proteins at an intermediate stage of progesterone receptor assembly, and is required for efficient assembly of mature receptor complexes in vitro. A largely untested hypothesis is that Hop functions as an adaptor that targets Hsp90- to Hsp70-substrate complexes; if true, then loss of either Hsp70 binding or Hsp90 binding by Hop should equally disrupt its ability to promote assembly of mature receptor complexes. To generate Hop mutants that selectively disrupt heat shock protein interactions, highly conserved amino acids in the previously mapped Hsp70 and Hsp90 binding domains of Hop and in a conserved C-terminal domain were targeted for small substitutions and deletions. In co-precipitation assays, these mutants displayed selective loss of association with heat shock proteins. In assays using Hop-depleted rabbit reticulocyte lysate for the cell-free assembly of receptor complexes, none of the Hop mutants inhibited Hsp70 binding to receptor, but all mutants were defective in supporting Hsp90-receptor interactions. Thus, Hop has a novel role in the chaperone machinery as an adaptor that can integrate Hsp70 and Hsp90 interactions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9857057     DOI: 10.1074/jbc.273.52.35194

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  121 in total

1.  Multiple components of the HSP90 chaperone complex function in regulation of heat shock factor 1 In vivo.

Authors:  S Bharadwaj; A Ali; N Ovsenek
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  Polypeptide release by Hsp90 involves ATP hydrolysis and is enhanced by the co-chaperone p23.

Authors:  J C Young; F U Hartl
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

Review 3.  Hsp70 interactions with the p53 tumour suppressor protein.

Authors:  M Zylicz; F W King; A Wawrzynow
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

4.  In vitro reconstitution of functional hepadnavirus reverse transcriptase with cellular chaperone proteins.

Authors:  Jianming Hu; David Toft; Dana Anselmo; Xingtai Wang
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo.

Authors:  Daniel L Riggs; Patricia J Roberts; Samantha C Chirillo; Joyce Cheung-Flynn; Viravan Prapapanich; Thomas Ratajczak; Richard Gaber; Didier Picard; David F Smith
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

6.  Small glutamine-rich protein/viral protein U-binding protein is a novel cochaperone that affects heat shock protein 70 activity.

Authors:  Peter C Angeletti; Doriann Walker; Antonito T Panganiban
Journal:  Cell Stress Chaperones       Date:  2002-07       Impact factor: 3.667

7.  Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery.

Authors:  Philippe Meyer; Chrisostomos Prodromou; Chunyan Liao; Bin Hu; S Mark Roe; Cara K Vaughan; Ignacija Vlasic; Barry Panaretou; Peter W Piper; Laurence H Pearl
Journal:  EMBO J       Date:  2004-01-22       Impact factor: 11.598

8.  A proteomic approach for the discovery of protease substrates.

Authors:  Andrew J Bredemeyer; Renate M Lewis; James P Malone; Alan E Davis; Julia Gross; R Reid Townsend; Timothy J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

9.  The molecular chaperone Hsp70 activates protein phosphatase 5 (PP5) by binding the tetratricopeptide repeat (TPR) domain.

Authors:  Jamie N Connarn; Victoria A Assimon; Rebecca A Reed; Eric Tse; Daniel R Southworth; Erik R P Zuiderweg; Jason E Gestwicki; Duxin Sun
Journal:  J Biol Chem       Date:  2013-12-10       Impact factor: 5.157

Review 10.  New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential.

Authors:  Yanyan Li; Tao Zhang; Steven J Schwartz; Duxin Sun
Journal:  Drug Resist Updat       Date:  2009 Feb-Apr       Impact factor: 18.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.